Drug recall · May 21, 2025
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment recall
Why: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
- Lots / codes
Lot #: MYX46W, Exp 04/30/2025
- Quantity
- 2,226,801 bottles
- Company
- L'Oreal USA, Clark, NJ
- Distribution
- Nationwide in the USA
- Initiated
- March 5, 2025 · Voluntary: Firm initiated
- Classified
- May 9, 2025
- Reported
- May 21, 2025
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Benzoyl peroxide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.